Current treatment status-Undergoing active treatment - Page 23 of 29 Posts on Medivizor
Navigation Menu

Current treatment status-Undergoing active treatment Posts on Medivizor

Significance of prostate specific antigen in metastatic prostate cancer survival

Significance of prostate specific antigen in metastatic prostate cancer survival

Posted by on Aug 23, 2015 in Prostate cancer | 1 comment

In a nutshell The authors determined the significance of prostate specific antigen (PSA) levels in determining survival in prostate cancer patients with bone tumors after hormone therapy Some background Hormone therapy is a common treatment for prostate cancer. It targets the male sex hormones active in prostate cancer, such as testosterone....

Read More

Can a trastuzumab-combination chemotherapy treatment cause skin and nail infections?

Can a trastuzumab-combination chemotherapy treatment cause skin and nail infections?

Posted by on Jul 21, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to determine whether severe skin and nail infections observed in patients with breast cancer were due to a combination-chemotherapy treatment. Some background Trastuzumab (Herceptin) is a common drug used to treat patients with human epidermal growth factor 2 positive (HER2+) breast cancer. The HER2 protein can...

Read More

Retargeting: Treatment for metastatic HER2+ breast cancer that has progressed following targeted treatment

Retargeting: Treatment for metastatic HER2+ breast cancer that has progressed following targeted treatment

Posted by on Jul 18, 2015 in Breast cancer | 0 comments

In a nutshell The authors reviewed the benefits and safety of ado–trastuzumab emtansine (Kadcyla), a treatment for metastatic breast cancer (cancer that has spread to other areas of the body). Some background Human epidermal growth factor receptor 2 positive (HER2) breast cancer depends on HER2 for growth. Treatments that target the HER2...

Read More

Utility of genomic scoring in prostate cancer

Utility of genomic scoring in prostate cancer

Posted by on Jun 27, 2015 in Prostate cancer | 0 comments

In a nutshell The authors evaluated a scoring system known as genomic classifier (GC) score that could indicate spread of cancer in prostate canecr patients after surgery and radiation therapy. Some background Prostate surgery and radiation therapy are common treatments in prostate cancer. Prostate surgery involves...

Read More

Breast cancer; what are the risks of cancer returning following surgery?

Breast cancer; what are the risks of cancer returning following surgery?

Posted by on Jun 24, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess the overall risks of breast cancer recurrence (return of the cancer) following two types of breast cancer surgery. Some background Breast cancer treatments may include surgery; a mastectomy is the removal of the entire breast while breast-conserving surgery is the removal of the breast cancer but not the...

Read More

Benefits of preventive radiation therapy to the head in stage III-N2 non-small cell lung cancer

Benefits of preventive radiation therapy to the head in stage III-N2 non-small cell lung cancer

Posted by on Jun 14, 2015 in Lung cancer | 0 comments

In a nutshell The authors evaluated the benefits of preventive radiation therapy in patients with non-small cell lung cancer (NSCLC) who have high risk of developing brain metastases (spreading of cancer from the lungs to the brain). Some background NSCLC is the most common type of lung cancer, accounting for 85% of all lung cancers. In...

Read More